Showing results (201-210 of 256) with videos related to
Sort By:
Pageof 26
Frontiers in Oncology|July 1, 2021
Different Patient Subgroup Different Maintenance, Proteasome Inhibitors or Immunomodulators Maintenance for Newly Diagnosed Multiple Myeloma: A 7-Year Single-Center Date in ChinaXiaoyan Han, Chunxiang Jin, Gaofeng Zheng, et al.Cancer Management and Research|June 14, 2019
Acute myeloid leukemia patient with FLT3-ITD and NPM1 double mutation should undergo allogeneic hematopoietic stem cell transplantation in CR1 for better prognosisYan Huang, Juan Hu, Ting Lu, et al.Frontiers in Oncology|September 20, 2021
Corrigendum: Different Patient Subgroup Different Maintenance, Proteasome Inhibitors or Immunomodulators Maintenance for Newly Diagnosed Multiple Myeloma: A 7-Year Single-Center Data in ChinaXiaoyan Han, Chunxiang Jin, Gaofeng Zheng, et al.Cancer Science|October 26, 2023
Outcomes of COVID-19 in multiple myeloma patients treated with daratumumabDian Jin, Jingsong He, Wenjun Wu, et al.BMC Cancer|November 25, 2023
Impact of sex on treatment-related adverse effects and prognosis in nasopharyngeal carcinomaLinchong Cui, Zilu Chen, Fangfang Zeng, et al.Leukemia Research|March 1, 2011
Imatinib combined with myeloablative allogeneic hematopoietic stem cell transplantation for advanced phases of chronic myeloid leukemiaYi Luo, Yanmin Zhao, Yamin Tan, et al.Cancer Biology & Therapy|September 19, 2024
The correlation between serum bone metabolism indexes and bone disease and survival in newly diagnosed multiple myeloma patientsLinlin Huang, Yi Zhong, Qingxiao Chen, et al.Journal of General Internal Medicine|July 12, 2008
Patient reported receipt of medication instructions for warfarin is associated with reduced risk of serious bleeding eventsJoshua P Metlay, Sean Hennessy, A Russell Localio, et al.Experimental Hematology & Oncology|June 1, 2017
Clinical implications of c-maf expression in plasma cells from patients with multiple myelomaGuoQing Wei, LiJun Wang, HanJin Yang, et al.Cell Research|April 7, 2010
Mesenchymal stem cells: a new strategy for immunosuppression and tissue repairYufang Shi, Gangzheng Hu, Juanjuan Su, et al.Pageof 26